HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Pan, J. Articles by Feitelson, M. A. Search for Related Content PubMed PubMed Citation Articles by Pan, J. Articles by Feitelson, M. A. Agricola Articles by Pan, J. Articles by Feitelson, M. A.

Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-B

Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Room 222 Alumni Hall, 1020 Locust Street, Philadelphia, PA 19107-6799, USA¹
Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA²
GenWay Biotech, Inc., Suite E-2 Welsh Commons, 1364 Welsh Road, North Wales, PA 19454, USA³

Author for correspondence: Mark Feitelson (at Department of Pathology, Anatomy and Cell Biology). Fax +1 215 503 9982. e-mail Mark.Feitelson{at}mail.tju.edu

The hepatitis B virus-encoded X antigen (HBxAg) may contribute to the development of liver cancer, in part, by stimulating the growth and survival of infected cells in the face of ongoing immune responses. Given that the Fas ligand/receptor system contributes to the pathogenesis of chronic hepatitis B, experiments were designed to test the hypothesis that HBxAg mediates resistance of liver cells to anti-Fas killing. Accordingly, when HBxAg was introduced into HepG2 cells, it rendered these cells partially resistant to killing by anti-Fas. In HepG2 cells replicating virus, protection against anti-Fas killing was also observed, but to a lesser extent. Survival correlated with the activation of nuclear factor kappa B (NF-B) by HBxAg. Sensitivity to anti-Fas was observed in control cells, and was re-established in HepG2X cells stably transfected with the dominant negative inhibitor of NF-B, IB. HBxAg activation of NF-B was also associated with decreased levels of endogenous IB mRNA. Hence, HBxAg stimulation of NF-B promotes the survival of liver cells against Fas killing. This may contribute to the persistence of infected hepatocytes during chronic infection.

This article has been cited by other articles:

				J. Pan, Z. Lian, S. Wallet, and M. A. Feitelson The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor {alpha}-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin J. Gen. Virol., December 1, 2007; 88(12): 3275 - 3285. [Abstract] [Full Text] [PDF]

				M E Guicciardi and G J Gores Apoptosis: a mechanism of acute and chronic liver injury Gut, July 1, 2005; 54(7): 1024 - 1033. [Full Text] [PDF]

				M. J. Bouchard and R. J. Schneider The Enigmatic X Gene of Hepatitis B Virus J. Virol., December 1, 2004; 78(23): 12725 - 12734. [Full Text] [PDF]

				J. Pan, M. Clayton, and M. A. Feitelson Hepatitis B virus X antigen promotes transforming growth factor-{beta}1 (TGF-{beta}1) activity by up-regulation of TGF-{beta}1 and down-regulation of {alpha}2-macroglobulin J. Gen. Virol., February 1, 2004; 85(2): 275 - 282. [Abstract] [Full Text] [PDF]

				M. A. Medici, M. T. Sciortino, D. Perri, C. Amici, E. Avitabile, M. Ciotti, E. Balestrieri, E. De Smaele, G. Franzoso, and A. Mastino Protection by Herpes Simplex Virus Glycoprotein D against Fas-mediated Apoptosis: ROLE OF NUCLEAR FACTOR {kappa}B J. Biol. Chem., September 19, 2003; 278(38): 36059 - 36067. [Abstract] [Full Text] [PDF]

				W.-L. Shih, M.-L. Kuo, S.-E. Chuang, A.-L. Cheng, and S.-L. Doong Hepatitis B Virus X Protein Activates a Survival Signaling by Linking Src to Phosphatidylinositol 3-Kinase J. Biol. Chem., August 22, 2003; 278(34): 31807 - 31813. [Abstract] [Full Text] [PDF]

				C. R. Madden, M. J. Finegold, and B. L. Slagle Altered DNA Mutation Spectrum in Aflatoxin B1-Treated Transgenic Mice That Express the Hepatitis B Virus X Protein J. Virol., October 11, 2002; 76(22): 11770 - 11774. [Abstract] [Full Text] [PDF]

				J. G. Tralhao, J. Roudier, S. Morosan, C. Giannini, H. Tu, C. Goulenok, F. Carnot, F. Zavala, V. Joulin, D. Kremsdorf, et al. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: An alternative mechanism of HBx-related pathogenesis PNAS, May 14, 2002; 99(10): 6991 - 6996. [Abstract] [Full Text] [PDF]

				W. M. HON, K. H. LEE, and H. E. KHOO Nitric Oxide in Liver Diseases: Friend, Foe, or Just Passerby? Ann. N.Y. Acad. Sci., May 1, 2002; 962(1): 275 - 295. [Abstract] [Full Text] [PDF]

				H. Tu, C. Bonura, C. Giannini, H. Mouly, P. Soussan, M. Kew, P. Paterlini-Brechot, C. Brechot, and D. Kremsdorf Biological Impact of Natural COOH-Terminal Deletions of Hepatitis B Virus X Protein in Hepatocellular Carcinoma Tissues Cancer Res., November 1, 2001; 61(21): 7803 - 7810. [Abstract] [Full Text] [PDF]